Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology.  His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.For More Videos, please see below:Lymphoma Cancer Treatment NY - Weill Cornell
Hi there!
Be the first to review!
First-classBetter than mostAbout what I expectedNot the worst...Disappointing
Click to Rate

More Business Info

Location
C V Starr Pavillion
Categories
Physicians & Surgeons, Oncology, Physicians & Surgeons, Physicians & Surgeons, Hematology (Blood), Physicians & Surgeons, Internal Medicine
Provided by